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Background: Selenium (Se) is a necessary element for the biosynthesis of thyroid hormones. We investigated the
relationship between selenium status, thyroid volume, and goiter in a cross-sectional study in an iodine-sufficient area.
Methods: We selected residents of Chengdu (over 18 years old and living in the city for more than 5 years) using a
stratified cluster sampling technique. Fifteen hundred subjects were selected for the study, which involved a
questionnaire survey, physical examination, thyroid ultrasound, serum thyroid function test, and determination of
serum selenium level. Thyroid volume was calculated from the thickness, width, length, and a corrective factor for each
lobe. Ultimately, 1,205 subjects completed the investigation and were included in our study. Additionally, 80 school-age
children were selected to provide urine samples for urinary iodine analysis. We analyzed the data using appropriate
nonparametric and parametric statistical tests.
Results: The median urinary iodine value was 184 μg/L in school-age children, indicating iodine sufficiency. The median
serum selenium level of the 1,205 subjects was 52.63 (interquartile range [IQR] : 40.40-67.00) μg/L. The median thyroid
volume was 9.93 (IQR: 7.71-12.57) mL; both log-transformed serum selenium and log-transformed thyroid volume were
Gaussian distributions (P = .638 and P = .046, respectively). The prevalences of goiter and thyroid nodules were 8.8% and
18.6%. The prevalences of positive thyroid autoantibodies, thyroperoxidase autoantibodies and thyroglobulin
autoantibodies were 16.7%, 12.0%, and 11.1%, respectively. In the general linear regression model, there were
positive associations between serum selenium and age, and body mass index. We found no association between
serum selenium and thyroid-stimulating hormone. In simple linear regression analyses, we found no association
between thyroid volume and serum selenium. There were no significant differences in serum selenium between
persons with or without goiter. Serum selenium was not a risk factor for goiter.
Conclusion: In our study population, serum selenium was neither associated with thyroid volume nor with
goiter in an iodine-sufficient area. More studies should be conducted by following non-goitrous persons over
time and monitoring their selenium status.
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Both iodine and selenium are essential micronutrients
for proper thyroid function. Iodine is a main component
of the thyroid hormones thyroxine (T4) and triiodothyr-
onine (T3). The trace element selenium is a component
of selenocysteine and has an important role in normal
thyroid hormone metabolism; it is involved in the cataly-
sis of all known selenoenzymes (e.g., iodothyronine deio-
dinases and glutathione peroxidase). Compared with other
organs, the thyroid has the highest selenium concentra-
tion [1]. Thyroxine is produced exclusively in the thyroid
gland, and it may be converted to biologically active tri-
iodothyronine by the iodothyronine 5′-deiodinases in the
peripheral tissue. Hypothyroidism or hyperthyroidism will
occur when the thyroid gland cannot provide appropriate
thyroid hormones. On the other hand, the antioxidant
selenium protein glutathione peroxidase can protect the
thyrocytes from any excess hydrogen peroxide, which is
produced during thyroid hormone biosynthesis [2].
Different populations vary considerably in serum sel-
enium concentrations. Selenium levels can be influenced
by a number of factors such as ethnicity, dietary habits
and individual bioavailability of selenium [3]. For clinical
researchers, it is difficult to compare studies on serum
selenium and thyroid goiter. Researchers have investi-
gated the relationship between thyroid volume, goiter,
and serum selenium, but some have not taken into ac-
count the influence of iodine nutrition status on thyroid
volume. Some trials have investigated populations with
concurrent iodine deficiency [4-6], while others have
failed to describe the iodine status of a population [7].
However, iodine nutritional status in a population seems
to be a key factor in maintaining normal thyroid volume
and function [8,9]. Therefore, selenium’s effect on goiter
in iodine-deficient areas is not yet clear. Until now,
there were also few data on the influence of selenium on
thyroid volume in iodine-sufficient areas. We investi-
gated the relationship between thyroid volume, goiter,
and serum selenium.
Methods
All subjects in this study came from a community in
Chengdu (1 of 10 cities selected for epidemiological in-
vestigations of thyroid disease in China). Fifteen hundred
residents who had lived in Chengdu for at least 5 years
and were more than 18 years old were selected using
a stratified cluster sampling technique. The response
rate was 80.3%. The 1,205 subjects that completed the
investigation were included in this analysis. The exclu-
sion criteria for the study were as follows: (1) Women
who were pregnant or less than one year postpartum;
(2) subjects taking glucocorticoids, dopamine, or do-
butamine; (3) subjects taking antiepileptic drugs (pheny-
toin, carbamazepine, or others); (4) subjects sufferingfrom adrenocortical insufficiency, renal insufficiency,
or other serious systemic disease or chronic wasting
disease; or (5) a person receiving amiodarone or an iodine-
containing contrast agent within the past 6 months.
All the participants were asked to complete a self-
assessment questionnaire that included demographic
data, reproductive history, history of smoking and previ-
ous thyroid disease, and family history of thyroid dis-
ease. Height, weight, and blood pressure were measured
in all participants. Fasting blood samples were collected
and centrifuged at 3,000 revolutions per minute for
5 minutes. Sera were decanted for storage at −20°C until
assayed. Fasting urine specimens from 80 school-age
children from a school in the community were collected
and frozen (−20°C).
A thyroid ultrasonography was performed with a
7.5 MHz (LOGIQ 500, GE Healthcare, China). Thyroid
volume was calculated by multiplying the thickness,
width, length, by a corrective factor (0.479) for each lobe
[10]. The diameter of thyroid nodules was measured
and recorded. The thyroid echo pattern was classified as
isoecho, hyperecho, hypoecho, and heterogeneous echo.
The study was approved by the ethics committee of
West China Hospital, Sichuan University. Participants
signed a consent form after being informed verbally about
the study.Laboratory methods
Thyroid function and thyroid autoantibodies were mea-
sured using chemiluminescence immunoassay kits (Roche
Kit, Cobas-e601 analyzer). Intraassay and interassay coeffi-
cient of variation were all less than 5%. Thyroperoxidase
autoantibody (TPOAb), thyroglobulin autoantibody (TgAb),
and thyroid stimulating hormone (TSH) were measured in
all participants. If TSH was <0.71 mU/L, the free thyroxine
(FT4) and free triiodothyronine (FT3) were also measured
in the same sample. If TSH was >6.25 m U/L, then only
FT4 was measured. Serum selenium was determined by
hydride generation atomic fluorescence spectrometry
(HG-AFS) using a method described elsewhere [11]. Serum
was digested in a mixture of concentrated HNO3 and
HC1O4 (V: V = 4:1) first and then determined by HG-AFS.
During the process of digestion, the temperature was kept
below 180°C to prevent selenium from volatilizing. Di-
gestion was continued at 180°C until the solution became
clear. The solutions of HCL (V:V = 1:20) and KBH4
(M:V = 1.5:100) diluted by deionized water were used
as the carrier liquid and reducing agent, respectively.
The median urinary iodine was measured by As-Ce cata-
lytic chromatography. Laboratory reference values were
12 to 22 pmol/L for FT4, 3.1 to 6.8 pmol/L for FT3,
0.71 to 6.25 mU/L for TSH, <34 IU/mL for TPOAb,
and <115 IU/mL for TgAb.
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Clinical hyperthyroidism (overt thyrotoxicosis) was defined
as a TSH < 0.71 mU/L and an FT4 >22 pmol/L, and/or a
TSH <0.71 mU/L and an FT3 > 6.8 pmol/L. Subclinical
hyperthyroidism (subclinical thyrotoxicosis) was based
on a normal FT4 and FT3, and a TSH <0.71 mU/L.
Clinical hypothyroidism (overt hypothyroidism) was
defined as a TSH >6.25 mU/L and FT4 <12 pmol/L.
Subclinical hypothyroidism was based on a normal FT4
and TSH >6.25 mU/L.
Goiter was defined as a thyroid volume exceeding
18.8 mL for males and 14.4 mL for females. The cut-off
levels were derived from the mean (+2 SD) thyroid
volume in 597 subjects (315 males and 282 females)
without thyroid dysfunction, without a previous thy-
roid disease, without a family history of thyroid disease,
without positive thyroid autoantibodies, and without
goiter or nodules on ultrasonography [12].Statistical methods
Data processing was done with the SPSS version 16.0
(Chicago, SPSS Inc.). Laboratory values were reported as
mean ± SD, percentage, median, and interquartile range,
where approximately. Normality of the data distribution
was assessed with the Kolmogorov-Smirnov test. For
continuous variables, nonparametric statistics (Mann–
Whitney or Kruskal-Wallis), and parametric statistics
(t test) were all used, as appropriate. Group differences
in the numbers of subjects were analyzed using the
chi-square test. The relationship between serum selenium
concentration and thyroid volume was investigated by
simple and multivariate linear regression, with log-
transformed thyroid volume as the dependent variable.
The relationship between selenium status and thyroid
goiter was examined by univariate and multivariate
logistical regression. Apart from serum selenium levels,Figure 1 Distribution of serum selenium (log scaled) and thyroid volu
Test for ln-selenium (P = .638) and ln-thyroid volumes (P =0.046).the following variables were included in the models: age,
gender, smoking, body mass index (BMI), TSH concen-
trations, thyroid nodules, and thyroid echogenicity. The
level of significance was set at 5%.
The serum selenium concentration and thyroid volume
distribution in the 1,205 subjects were skewed, but
showed a normal distribution after log transformation
(Figure 1).Results
The median urine iodine (MUI) in the 80 school-age
children was 184 μg/L. In the 1,205 subjects, the preva-
lences of overt hyperthyroidism, subclinical hyperthyroid-
ism, overt hypothyroidism and subclinical hypothyroidism
were 0.91%, 1.99%, 0.91% and 5.81%, respectively. Distri-
bution of several variables among males and females are
shown in Table 1. The prevalences of thyroid nodules and
thyroid goiter in females were significantly higher than in
males (nodules: 22.1% vs. 14.1%, P = .001; goiter: 11.1% vs.
5.8%, P = .001), as were the prevalences of positive TPOAb
and TgAb (TPOAb: 15.6% vs. 5.8%, P = .001; TgAb: 15.7%
vs. 5.3%, P = .001).Serum selenium
In general linear univariate regression models, a positive
association between serum selenium concentration and
age was found (β = 0.080 ± 0.001, P = .006), and between
the serum selenium concentration and BMI (β = 0.057 ±
0.003, P = .049). We found no association between serum
TSH and selenium concentration (Spearman correlations,
r = −0.003, P = .906). One hundred-six (8.8%) of the 1,205
subjects had thyroid goiters, with a median serum selen-
ium concentration of 53.88 (IQ, 41.74-67.78) μg/L. The
non-goiter group had a median serum selenium concen-
tration of 52.54 (IQ, 40.23-66.89) μg/L. There was no
significant difference in selenium levels between themes (log scaled) for all patients. One-Sample-Kolmogorov-Smirnov
Table 1 Clinical and biological characteristics in men and women (N = 1,205)
Total Male Female
P
n = 1205 n = 531 (44.07%) n = 674 (55.93%)
Age (yr)* 46.31 ± 15.14 45.49 ± 15.82 46.95 ± 14.56 0.100***
Se (μg/L)** 52.63 (40.40-67.0) 51.63 (39.41-66.23) 53.14 (40.94-67.9) 0.191***
TV (mL)** 9.93 (7.71-12.57) 10.83 (8.86-13.50) 9.10 (7.26-11.57) 0.001‡
Nodularity N (%) 224 (18.6) 75 (14.1) 149 (22.1) 0.001‡
Goiter N (%) 106 (8.8) 31 (5.8) 75 (11.1) 0.001‡
TPOAb (+) n (%) 145 (12.0) 40 (7.5) 105 (15.6) 0.001‡
TgAb (+) n (%) 134 (11.1) 28 (5.3) 106 (15.7) 0.001‡
Antibody (+) n (%) 201 (16.7) 49 (9.2) 152 (22.6) 0.001‡
TSH (mU/L) 2.66 (1.81-3.66) 2.45 (1.73-3.54) 2.92 (1.9-4.13) 0.001‡‡
BMI (kg/m2) 22.90 ± 3.24 23.25 ± 3.03 22.62 ± 3.37 0.001***
Se: Selenium; TV:Thyroid volume.
Goiter: thyroid volume ≥ 14.4 mL in female, ≥18.7 L in male; TPOAb (+): TPOAb positive; TgAb (+): TgAb positive; antibody (+): TPOAb and/or TgAb positive.
*Mean ± standard deviation.
**Median (interquartile range).
***t test or log-transformed t test (selenium and thyroid volume).
‡Chi-square test.
‡‡Mann–Whitney U test.
Table 2 Simple and multivariate linear regression
analyses of thyroid volume* on determinants
β 95% CI P
Simple linear regression
Age (yr) 0.065 0.000-0.003 .023
BMI (kg/m2) 0.149 0.012-0.026 .001
TSH (mU/L) −0.136 −0.024-–0.010 .001
*Serum selenium (μg/L) 0.001 −0.059-0.061 .977
Smoking 0.112 0.055-0.164 .001
TPOAb positive 0.165 0.137-0.278 .001
TgAb positive 0.146 0.118-0.264 .001
Antibody positive 0.163 0.118-0.241 .001
Nodules 0.219 0.173-0.289 .001
Multivariate linear regression
BMI (kg/m2) 0.126 0.009-0.023 .001
TSH (mU/L) −0.176 −0.029-–0.015 .001
Smoking 0.120 0.064-0.169 .001
TPOAb positive 0.139 0.098-0.253 .001
TgAb positive 0.106 0.059-0.218 .001
Nodules 0.218 0.174-0.285 .001
*Logarithmic transformation was used to normalize the distribution.
Antibody positive:POAb and/or TgAb positive.
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were no differences in selenium levels between persons
with nodules and without nodules (50.66 vs. 52.80,
log-transformed t-test, P = .126). Similarly, there were
no differences in selenium levels between positive
and negative TPOAb, and positive and negative TgAb
(P >0.05).
Thyroid volume
Parameters estimated from the simple linear regression
analysis between thyroid volume and variables that
might influence thyroid volume are reported in Table 2.
In the univariate analyses, there was no association be-
tween serum selenium and thyroid volume for all sub-
jects (P = .977), nor in females or males (P > 0.05). Age,
BMI, smoking, thyroid nodules, and positive TPOAb or
TgAb were significantly and positively associated with
thyroid volume (P < 0.05). TSH levels were negatively
associated with thyroid volume (P = .001), and for every
1 mU/L TSH concentration increase, thyroid volume
decreased by 0.136 mL. In the multiple linear regression
model, after adjustment for age and gender, BMI, TSH,
smoking, thyroid nodules, and positive thyroid autoanti-
bodies influenced thyroid volume in the final regression
model.
Thyroid goiter
When the presence or absence of goiter was studied in
our population, serum selenium was not an independent
risk factor for the development of goiter (P = .305, OR =
1.004) (Table 3). In the univariate logistic regressionmodel, BMI, thyroid nodules, positive TPOAb, positive
TgAb, and thyroid hypoecho or uneven echo were risk
factors for thyroid goiter. In the multivariate analysis,
the final model retained the following variables: age, thy-
roid nodules, and positive thyroid autoantibodies (TPOAb
Table 3 Logistic regression analyses for risk of goiter
OR (95%CI) P
Univariate logistic regression
Age (yr) 1.001 (0.998-1.014) .871
BMI (kg/m2) 1.067 (1.012-1.125) .016
TSH (mU/L) 0.997 (0.936-1.016) .914
Serum selenium (μg/L) 1.004 (0.996-1.013) .305
Smoking
Heavy smoker 0.757 (0.428-1.338) .338
Moderate smoker 0.403 (0.124-1.306) .130
Nodules 0.230 (0.152-0.349) .001
TPOAb positive 4.920 (3.150-7.686) .001
TgAb positive 4.227 (2.663-6.709) .001
Antibody positive 4.669 (3.068-7.106) .001
Interecho
Hypoecho 3.808 (2.281-6.356) .001
Hyperecho 1.489 (0.187-11.992) .703
Uneven echo 3.570 (1.648-7.731) .001
Multivariate logistic regression
Age (yr) 0.979 (0.964-0.994) .006
BMI (kg/m2) 1.079 (1.021-1.141) .007
Nodules 5.388 (3.359-8.641) .001
Antibody positive 4.906 (3.148-7.647) .001
Antibody positive: TPOAb and/or TgAb positive.
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the presence of thyroid goiter and increasing age (β = 0.979,
P = .006).
Discussion
The median serum selenium concentration in the Chengdu
community population was 52.63 (IQ, 40.40-67.00) μg/L,
a relatively lower level compared with other regions. The
average serum selenium was 75 μg/L in the Zhoukou dian
area [13] in Beijing, 61.84 μg/L in Jinan residents [14],
132 μg/L in Canada [15], 120 μg/L in the United States
[16], and 58.94 μg/L in non-goitrous areas in Turkey [17].
The differences in serum selenium concentration in diffe-
rent regional populations may be due to race, geographical
environment, physiological status, eating habits, smoking,
and the determination methodology for selenium.
Both iodine and selenium play an important role in
the proper function and structure of the thyroid gland.
The abnormality of iodine and selenium nutrition in
populations can result in thyroid dysfunction and abnor-
mal thyroid structure. Studies have shown that concur-
rent severe selenium and iodine deficiency can lead to
an increase in thyroid volume and/or TSH levels [4-6],possibly because thyroid iodine deficiency stimulates the
synthesis of thyroid hormones, under TSH control, leading
to an increased production of hydrogen peroxide, which
is the electron acceptor for the thyroid peroxidase reac-
tion in the synthesis of thyroid hormones. However,
when produced excessively, hydrogen peroxide is toxic
for thyroid cells [18]. As in other cells in the body, the
family glutathione peroxidase, superoxide dismutase, and
catalase can protect thyroid cells from hydrogen peroxide
damage. On the other hand, selenium deficiency can
result in lower activity of thyroid glutathione peroxid-
ase, consequently reducing the degradation of hydrogen
peroxide. Thus, a simultaneous selenium and iodine defi-
ciency reduces the activity of thyroid glutathione perox-
idase and increases hydrogen peroxide, leading to thyroid
cell damage due to the highly reactive peroxides of hydro-
gen peroxide [19]. Selenium levels probably affect thyroid
volume in areas of severe iodine deficiency, while selenium
levels seem unassociated with thyroid goiter in iodine-
sufficient regions. This speculation was confirmed in
our study. The mean MUI levels of the school-age chil-
dren in our study were 184 μg/L in our iodine-sufficient
region [20]. We found that the serum selenium concen-
tration was not associated with goiter nor did it influ-
ence thyroid volume and TSH levels. This might be
because our study population lives in an area with suffi-
cient iodine and relatively low serum selenium. The
results of a Danish study [21] are consistent with our
findings. Before introduction of iodine fortification, the
MUI level was 57 μg/L, and the serum selenium concen-
tration was significantly and negatively associated with a
risk for an enlarged thyroid gland. However, the MUI was
100 μg/L after iodine fortification in the Danish regions,
and the serum selenium concentration was no longer
an independent risk factor for thyroid goiter. Therefore,
to investigate the effect of serum selenium on thyroid
volume and thyroid goiter, we need to determine the
nutritional iodine status to eliminate the effect of differ-
ent iodine levels on thyroid volume and goiter.
The status of serum selenium has diverse effects on
thyroid volume and goiter in a mild iodine-deficient or
(borderline) iodine-sufficient area. John et al. [12] found
that when the intake of selenium was sufficient, there
was no correlation between goiter and serum selenium
levels even in a mild iodine-deficient area. A study in
school-age children in Turkey [22] with moderate iodine
deficiency, found that mean selenium was 50 μg/L, a
relatively low level, and serum selenium concentration
was not associated with thyroid volume, thyroid goiter,
or THS levels. They considered iodine deficiency the
major cause of thyroid goiter maybe because the serum
selenium concentration has little influence on glutathi-
one peroxidase and deiodinase in the thyroid gland in
borderline selenium-sufficient areas. However, Keshteli et al.
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tor of thyroid goiter in Isfahan goitrous schoolchil-
dren in an iodine-sufficient area. Another study [24]
from France, in a mild iodine-deficiency area, found a
negative correlation between serum concentration and
thyroid volume in 1,108 subjects. The mean serum selen-
ium in their study was 87 μg/L, which was higher than in
our population. The differences between these findings
may be that the all subjects in the French cohort study
were females and older (the mean age ranged from 45
to 60 years) than those in our study group. From this, it
can be concluded that different serum selenium concen-
trations have disparate effects on thyroid volume and
thyroid goiter. Serum selenium levels in the population
are affected by many other factors; there is still no exact
definition of selenium-deficient status. Further studies
should be carried out to explore the impact of selenium
concentration on thyroid volume and thyroid goiter in
(borderline) iodine-sufficient areas.
The lack of an exact definition of “selenium status”
may be another reason for varying results among studies
in addition to variations in iodine and selenium nutri-
tional status in different populations. In the literature,
the determination of “selenium status” includes serum
selenium, plasma glutathione peroxidase activity, erythro-
cyte glutathione peroxidase activity, urinary selenium, and
hair or toenail selenium. However, the exact interrelation-
ships among these parameters have not been determined.
Some studies have shown that urinary and serum selen-
ium concentrations are more likely to accurately reflect
the presence of selenium bioavailability in the human
body [25,26]. Ozata et al. [27] found that serum selenium
concentration did not seem to have a role in the etio-
pathogenesis of goiter in Turkey in a moderate iodine-
deficient area. Similarly, Brauer et al. [28] found that
urinary selenium was not an independent risk factor for
the development of goiter in an area with borderline
iodine sufficiency and borderline selenium sufficiency.
These two findings above are consistent with our results.
Therefore, we conclude that selenium concentration in
both serum and urine are reflective of selenium status in
the body, and to some extent, indicate selenium bio-
availability to the human body or thyroid gland.
Conclusions
We can conclude that serum selenium concentrations
in the Chengdu community population in China are at
relatively lower levels compared with other regions. In
our study population, serum selenium was neither asso-
ciated with thyroid volume nor with goiter in an iodine-
sufficient area. There are considerable variables that
influence selenium concentrations in populations. Moni-
toring the selenium status of nongoitrous persons over
time would help to clarify this issue.Competing interests
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